secwatch / observer
8-K filed October 27, 2022, 7:59 PM ET ticker AXTI CIK 0001051627
earnings confidence high sentiment positive materiality 0.70

AXT Q3 2022: Revenue $35.2M, GAAP EPS $0.13, Indium Phosphide revenue up 12% QoQ

AXT INC

2022-Q3 EPS reported $0.34 revenue$114,323,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

AXT INC reported quarter ended September 30, 2022 results: revenue $35.2 million, net income $5.8 million, EPS $0.13 per share.

Period
quarter ended September 30, 2022
Revenue
$35.2 million
Net income
$5.8 million
EPS
$0.13 per share
Result
reported results
Exact text from the filing
● Revenue for the third quarter of 2022 was $35.2 million, compared with $39.5 million for the second quarter of 2022 and $34.6 million for the third quarter of 2021. ​ ● GAAP gross margin was 42.0 percent of revenue for the third quarter of 2022, compared with 39.1 percent of revenue for the second quarter of 2022 and 33.3 percent for the third quarter of 2021. ​ ● Non-GAAP gross margin was 42.2 percent of revenue for the third quarter of 2022, compared with 39.4 percent of revenue for the second quarter of 2022 and 33.8 percent for the third quarter of 2021. ​ ​ ​ ​ AXT, Inc. Third Quarter 2022 Results ​ October 27, 2022 ​ Page 2 of 7 ​ ● GAAP operating expenses were $10.2 million for the third quarter of 2022, compared with $10.1 million for the second quarter of 2022 and $9.1 million for the third quarter of 2021. ​ ● Non-GAAP operating expenses were $9.2 million for the third quarter of 2022, compared with $9.1 million for the second quarter of 2022 and $7.7 million for the third
View on SEC.gov

Browse all earnings releases →

AXT INC filing history →

Source: SEC EDGAR
accession 0001558370-22-015506
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.